Automated lung tumor delineation on positron emission tomography/computed tomography via a hybrid regional network.


Journal

Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746

Informations de publication

Date de publication:
Jan 2023
Historique:
revised: 20 09 2022
received: 16 04 2021
accepted: 20 09 2022
pmc-release: 01 01 2024
pubmed: 8 10 2022
medline: 25 1 2023
entrez: 7 10 2022
Statut: ppublish

Résumé

Multimodality positron emission tomography/computed tomography (PET/CT) imaging combines the anatomical information of CT with the functional information of PET. In the diagnosis and treatment of many cancers, such as non-small cell lung cancer (NSCLC), PET/CT imaging allows more accurate delineation of tumor or involved lymph nodes for radiation planning. In this paper, we propose a hybrid regional network method of automatically segmenting lung tumors from PET/CT images. The hybrid regional network architecture synthesizes the functional and anatomical information from the two image modalities, whereas the mask regional convolutional neural network (R-CNN) and scoring fine-tune the regional location and quality of the output segmentation. This model consists of five major subnetworks, that is, a dual feature representation network (DFRN), a regional proposal network (RPN), a specific tumor-wise R-CNN, a mask-Net, and a score head. Given a PET/CT image as inputs, the DFRN extracts feature maps from the PET and CT images. Then, the RPN and R-CNN work together to localize lung tumors and reduce the image size and feature map size by removing irrelevant regions. The mask-Net is used to segment tumor within a volume-of-interest (VOI) with a score head evaluating the segmentation performed by the mask-Net. Finally, the segmented tumor within the VOI was mapped back to the volumetric coordinate system based on the location information derived via the RPN and R-CNN. We trained, validated, and tested the proposed neural network using 100 PET/CT images of patients with NSCLC. A fivefold cross-validation study was performed. The segmentation was evaluated with two indicators: (1) multiple metrics, including the Dice similarity coefficient, Jacard, 95th percentile Hausdorff distance, mean surface distance (MSD), residual mean square distance, and center-of-mass distance; (2) Bland-Altman analysis and volumetric Pearson correlation analysis. In fivefold cross-validation, this method achieved Dice and MSD of 0.84 ± 0.15 and 1.38 ± 2.2 mm, respectively. A new PET/CT can be segmented in 1 s by this model. External validation on The Cancer Imaging Archive dataset (63 PET/CT images) indicates that the proposed model has superior performance compared to other methods. The proposed method shows great promise to automatically delineate NSCLC tumors on PET/CT images, thereby allowing for a more streamlined clinical workflow that is faster and reduces physician effort.

Sections du résumé

BACKGROUND BACKGROUND
Multimodality positron emission tomography/computed tomography (PET/CT) imaging combines the anatomical information of CT with the functional information of PET. In the diagnosis and treatment of many cancers, such as non-small cell lung cancer (NSCLC), PET/CT imaging allows more accurate delineation of tumor or involved lymph nodes for radiation planning.
PURPOSE OBJECTIVE
In this paper, we propose a hybrid regional network method of automatically segmenting lung tumors from PET/CT images.
METHODS METHODS
The hybrid regional network architecture synthesizes the functional and anatomical information from the two image modalities, whereas the mask regional convolutional neural network (R-CNN) and scoring fine-tune the regional location and quality of the output segmentation. This model consists of five major subnetworks, that is, a dual feature representation network (DFRN), a regional proposal network (RPN), a specific tumor-wise R-CNN, a mask-Net, and a score head. Given a PET/CT image as inputs, the DFRN extracts feature maps from the PET and CT images. Then, the RPN and R-CNN work together to localize lung tumors and reduce the image size and feature map size by removing irrelevant regions. The mask-Net is used to segment tumor within a volume-of-interest (VOI) with a score head evaluating the segmentation performed by the mask-Net. Finally, the segmented tumor within the VOI was mapped back to the volumetric coordinate system based on the location information derived via the RPN and R-CNN. We trained, validated, and tested the proposed neural network using 100 PET/CT images of patients with NSCLC. A fivefold cross-validation study was performed. The segmentation was evaluated with two indicators: (1) multiple metrics, including the Dice similarity coefficient, Jacard, 95th percentile Hausdorff distance, mean surface distance (MSD), residual mean square distance, and center-of-mass distance; (2) Bland-Altman analysis and volumetric Pearson correlation analysis.
RESULTS RESULTS
In fivefold cross-validation, this method achieved Dice and MSD of 0.84 ± 0.15 and 1.38 ± 2.2 mm, respectively. A new PET/CT can be segmented in 1 s by this model. External validation on The Cancer Imaging Archive dataset (63 PET/CT images) indicates that the proposed model has superior performance compared to other methods.
CONCLUSION CONCLUSIONS
The proposed method shows great promise to automatically delineate NSCLC tumors on PET/CT images, thereby allowing for a more streamlined clinical workflow that is faster and reduces physician effort.

Identifiants

pubmed: 36203393
doi: 10.1002/mp.16001
pmc: PMC9868056
mid: NIHMS1841065
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-283

Subventions

Organisme : NCI NIH HHS
ID : R01 CA215718
Pays : United States
Organisme : NIBIB NIH HHS
ID : R56 EB033332
Pays : United States
Organisme : NIH HHS
ID : R01CA215718
Pays : United States
Organisme : NIH HHS
ID : R56EB033332
Pays : United States

Informations de copyright

© 2022 American Association of Physicists in Medicine.

Références

Phys Med Biol. 2015 Feb 21;60(4):R115-54
pubmed: 25650582
Phys Med. 2020 Aug;76:294-306
pubmed: 32738777
Comput Biol Med. 2014 Jul;50:76-96
pubmed: 24845019
Radiother Oncol. 2010 Sep;96(3):302-7
pubmed: 20708286
Inf Process Med Imaging. 2011;22:245-56
pubmed: 21761661
Curr Med Imaging. 2020;16(3):231-240
pubmed: 32133953
Med Phys. 2021 Jan;48(1):204-214
pubmed: 33128230
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:1998-2001
pubmed: 29060287
Med Phys. 2008 Apr;35(4):1207-13
pubmed: 18491512
Phys Med Biol. 2021 Feb 11;66(4):045021
pubmed: 33412527
Br J Cancer. 2019 Apr;120(8):779-790
pubmed: 30911090
Radiother Oncol. 2019 Dec;141:192-199
pubmed: 31630868
Neurocomputing. 2020 Jun 7;392:277-295
pubmed: 32773965
Annu Rev Biomed Eng. 2015;17:385-414
pubmed: 26643024
Stat Methods Med Res. 1994;3(3):211-26
pubmed: 7820292
J Nucl Med. 2006 Nov;47(11):1808-12
pubmed: 17079814
Med Phys. 2020 Sep;47(9):4316-4324
pubmed: 32654153
Phys Med Biol. 2017 Jul 06;62(15):6008-6025
pubmed: 28682793
Med Phys. 2021 Oct;48(10):5862-5873
pubmed: 34342878
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1385-92
pubmed: 15817341
Phys Med Biol. 2018 Dec 21;64(1):015011
pubmed: 30523964
J Nucl Med. 2007 Jun;48(6):932-45
pubmed: 17504879
Phys Med Biol. 2020 Sep 18;65(18):185009
pubmed: 32674075
PET Clin. 2021 Oct;16(4):553-576
pubmed: 34537130
Biochem Med (Zagreb). 2015 Jun 05;25(2):141-51
pubmed: 26110027
PLoS One. 2019 Jan 22;14(1):e0210075
pubmed: 30668601

Auteurs

Yang Lei (Y)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Tonghe Wang (T)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Jiwoong J Jeong (JJ)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

James Janopaul-Naylor (J)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Aparna H Kesarwala (AH)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Justin Roper (J)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Sibo Tian (S)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Jeffrey D Bradley (JD)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Tian Liu (T)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Kristin Higgins (K)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Xiaofeng Yang (X)

Department of Radiation Oncology and Winship Cancer Institute, Emory University, School of Medicine, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH